A detailed history of Bank Of Montreal transactions in Abb Vie Inc. stock. As of the latest transaction made, Bank Of Montreal holds 3,619,335 shares of ABBV stock, worth $618 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
3,619,335
Previous 3,950,674 8.39%
Holding current value
$618 Million
Previous $612 Million 7.65%
% of portfolio
0.34%
Previous 0.32%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $53 Million - $60.3 Million
-331,339 Reduced 8.39%
3,619,335 $659 Million
Q4 2023

Feb 08, 2024

BUY
$137.6 - $154.97 $27.7 Million - $31.2 Million
201,181 Added 5.37%
3,950,674 $612 Million
Q3 2023

Nov 01, 2023

BUY
$133.59 - $154.65 $32.2 Million - $37.3 Million
241,224 Added 6.88%
3,749,493 $559 Million
Q2 2023

Aug 02, 2023

BUY
$132.51 - $164.9 $77.5 Million - $96.5 Million
585,017 Added 20.01%
3,508,269 $473 Million
Q1 2023

Jun 13, 2024

SELL
$144.61 - $166.54 $86.2 Million - $99.3 Million
-596,060 Reduced 16.47%
3,023,275 $482 Million
Q4 2022

Feb 01, 2023

BUY
$138.31 - $165.87 $52.4 Million - $62.8 Million
378,685 Added 14.88%
2,923,252 $473 Million
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $48.4 Million - $55.5 Million
-360,663 Reduced 12.41%
2,544,567 $366 Million
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $22.4 Million - $28.5 Million
163,107 Added 5.95%
2,905,230 $448 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $30.9 Million - $38.4 Million
-234,315 Reduced 7.87%
2,742,123 $449 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $99.9 Million - $126 Million
-930,047 Reduced 23.81%
2,976,438 $405 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $23 Million - $26.1 Million
215,904 Added 5.85%
3,906,485 $426 Million
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $388 Million - $433 Million
3,690,581 New
3,690,581 $416 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $302B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.